Figshareopen access

Optimization of a Second-Generation, Highly Selective Polθ/PARP1 Dual Inhibitor with Improved Pharmacokinetics and Potent Activity against HR-Deficient Tumors

Name: Optimization of a Second-Generation, Highly Selective Polθ/PARP1 Dual Inhibitor with Improved Pharmacokinetics and Potent Activity against HR-Deficient Tumors
License: Open Access

Luyu Ma (13161471) et al.

Figshare · Datasets · License: Open Access

Open Source ↗

cancer medicine

medicine, molecular biology, pharmacology, biotechnology, cancer, infectious diseases, plant biology, biological sciences not elsewhere classified

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Optimization of a Second-Generation, Highly Selective Polθ/PARP1 Dual Inhibitor with Improved Pharmacokinetics and Potent Activity against HR-Deficient Tumors

Related documents